StockTipsArenaBeta

BUY Strides Pharma Science Limited — Rajesh Satpute

BUYStrides Pharma Science Limited
Strides Pharma Science share price target & all analyst calls

byRajesh SatputeHorizon: Swing (≤2wk)29 Jun 2026via CNBC Awaaz.

Entry₹1,100Stated
Target₹1,150
Total upside +4.55% (call closed)
Stop loss₹1,080-1.82% risk
Exit₹1,0808 Jul 2026, 2:15 pm
Stop-loss hit-1.82%
Follow Rajesh Satpute for new calls(32% target hit, 200 closed calls)Get alertsWatch STAR for new buy/sell callsGet alertsSee 149 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 8 Jul 2026
1 supporting0 opposing
Supports the BUY call (1)

Strides Pharma Science Ltd is partnering with Ascent Capital to unlock value in its Pivot Path initiative, suggesting a strategic move for value creation.

BSE · Company Update·27 Jun · 1w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Strides Pharma Science

All analyst calls on Strides Pharma Science

More from Rajesh Satpute

Every call and its outcome